Regenstrief Institute, Inc.的动态

The future of bioscience innovation is here. Today, we celebrated the official launch of IU Launch Accelerator for Biosciences (IU LAB) at 16 Tech Innovation District in Indianapolis. This first-of-its-kind academic-industry initiative, supported by a $138 million Lilly Endowment Inc. grant, will serve as a dynamic hub, driving collaboration between Indiana University and industry in critical areas of bioscience and health research, establishing Indiana as a global leader in bioscience innovation. We were honored to be joined by Governor Braun, Mayor Hogsett, David Rosenberg (the new president and CEO of IU LAB), Cook Medical President Pete Yonkman, and leaders from the Indiana Biosciences Research Institute, Regenstrief Institute, Inc., Indiana University Health, and Central Indiana Corporate Partnership. Their collaboration will ensure IU LAB thrives as a hub of innovation, driving advancements in healthcare, creating pathways for the next generation of bioscience leaders, and fueling the development of one of our state’s most vital industry sectors. IU LAB’s mission goes beyond research—it is about making a tangible impact on human health and transforming the local community. By fostering academic-industry partnerships, providing educational opportunities, and supporting IU entrepreneurs developing new startup companies, IU LAB will accelerate the commercialization of new biosciences discoveries and help empower local residents with career opportunities. This launch further solidifies Indiana University Indianapolis’ status as a premier urban research institution, amplifying its role as a leader in bioscience innovation and community transformation. It marks a pivotal moment in realizing the ambitious goals of the IU 2030 strategic plan, setting the stage for Indiana to lead in bioscience research and innovation. AcceLINX Adipo Therapeutics Aurorium BioCrossroads Eli Lilly and Company Hoosier Cancer Research Network INCOG BioPharma Services Indiana CTSI myBiometry OrthoWorx, Inc. Plug and Play Tech Center

This week we celebrated the official launch of IU Launch Accelerator for Biosciences (IU LAB) at 16 Tech Innovation District in Indianapolis. The remarks from Emily Krueger, President Whitten, Clay Robbins, David Rosenberg, Governor Braun, Mayor Hogsett, and Pete Yonkman demonstrated how leadership catalyzes collaboration. Supported by a $138 million Lilly Endowment Inc. grant, IU LAB will serve as a dynamic hub, driving collaboration between Indiana University and industry in critical areas of bioscience and health research, establishing Indiana as a global leader in bioscience innovation. Collaborative leadership drives progress toward a future we want.

The IU School of Medicine is proud to partner in the launch of IU LAB, with a strong focus on leading the translation of cutting-edge innovation and research into improved patient outcomes through advanced clinical trials, entrepreneurship, and commercialization.

We are thrilled to be part of this initiative, designed to further fuel our life sciences #workforce and establish Indiana as a global #biosciences leader. The IU Launch Accelerator for Biosciences (IU LAB) at the 16 Tech Innovation District is a collaborative effort that connects industry with #academia to drive advancements in #healthcare and accelerate the commercialization of innovative therapies. Indiana Biosciences Research Institute Regenstrief Institute, Inc. Eli Lilly and Company Indiana University Indianapolis #indiana #iu #lifesciences

A great kickoff to the IU Launch Accelerator for Biosciences (IU LAB) with Indiana University President Pamela Whitten, Lilly Endowment and Pete Yonkman of Cook Medical. The IU LAB is the front door where academia meets industry - driving innovation in human health. The IU LAB will harness IU's nearly $1 billion research enterprise and Indiana's $95 billion life science economy to be the national leader in discovery, commercialization and talent development. Follow our page as we embark on this ambitious initiative, and please reach out to discuss opportunities to collaborate with students, faculty, researchers, entrepreneurs, start-ups and leading industry partners as we drive groundbreaking research and innovation. Let's go change the world together. 16 Tech Innovation District Indiana Biosciences Research Institute Regenstrief Institute, Inc. Indiana University Health Central Indiana Corporate Partnership AcceLINX Adipo Therapeutics Aurorium BioCrossroads Eli Lilly and Company Hoosier Cancer Research Network INCOG BioPharma Services Indiana CTSI myBiometry OrthoWorx, Inc. Plug and Play Tech Center Elevate Ventures Zimmer Biomet Roche Russell Mumper Phaedra Corso Jillian Turner Matt Jaworowski Kurt Fullbeck Susan Brock Williams Vince Wong Dan Peterson

The official launch of IU LAB paves the way for unprecedented growth and innovation for the IU Indianapolis community and beyond. Located just minutes from campus, IU LAB will serve as a dynamic hub, driving collaboration between IU and industry in critical areas of bioscience and health research, establishing Indiana as a global leader in bioscience innovation.

Emerging Therapeutic Innovation Models: In last 2 years, venture and philanthropy deploy $4.5B across three companies for basic and translational research. One model claims to bypass limitations of NIH funding and academic institutions. High-level notes from press releases. Interested in your thoughts. 1. Funding: Arena $500M. Altos $3B. Xiara $1B 2. Focus: (a) Arena - determining the mechanisms of human disease and advancing new technologies to translate these insights into therapeutics through in-house biotech companies (b) Altos - restore cell health and resilience to reverse disease, injury, and the disabilities that can occur throughout life. (c) Xiara - AI Enabled Drug Discovery for traditionally undruggable targets. 3. Press Releases Arena - https://lnkd.in/e4hksYnD Altos - https://lnkd.in/etc-Ax44 Xiara - https://lnkd.in/e3-AiJjT

Get ready to be amazed by British Columbia's latest breakthroughs in Biotechnology! Check out our newest article featuring nine inspiring startups redefining the Biotech landscape in BC. Look into the story here: https://lnkd.in/gfGpyPEe You wouldn't want to miss the innovating work that these emerging startups are doing: 1. Avivo Biomedical Inc., pioneered by Geoff Houlton and John Barclay, innovating in cell surface antigens. 2. NanoVation Therapeutics? Therapeutics, mastering nanotechnology for efficient delivery of nucleic acid tissues. 3. HAVN Life - Co-Founded by Alexzander Samuelsson 4. Rakovina Therapeutics, led by the brilliant minds of Jeffrey Bacha and Mads Daugaard 5. Levitee Labs, founded by Kelly Abbott spotlighting integrative wellness space. 6. Capsigen, initiated by Charlie Kang and John Bial, focusing on engineering novel AAV capsids. 7. Axolotl Biosciences, revolutionizing 3D printing in the Biotech industry. 8. BugSeq Bioinformatics, an outstanding project from co-founders Josh Chorlton & Sam Chorlton. 9. Albert Labs, rapidly advancing drug development for mental health disorders. 10. Asep Medical Holdings Inc., established by Robert Hancock, revolutionizing the diagnosis of sepsis. 11. Purpose Life Sciences, aiming to redefine clinical trials globally. These companies are not only revolutionizing biotech, but also making British Columbia a global trending spot in the field. Let's appreciate their amazing work in healthcare, medical advancements, and life science! #Biotechnology #Startups #Innovation #Healthcare #LifeSciences #BCBusiness

Today, San Diego, is the fastest-growing biotech hub in the US? But how exactly did San Diego become the go-to destination for biotechnology? San Diego’s biotech story began back in 1955-1965 when leading research institutions such as the Salk Institute, Scripps, and the University of California San Diego (UCSD) were founded close to one another. City leaders designated Torrey Pines to scientific research and development. In 1978, two young UC San Diego academics named Ivor Royston and Howard Birndorf had an idea. He believed his research into monoclonal antibodies could be the future of disease diagnosis. He and his assistant, Howard Birndorf, hoped to begin making the antibodies commercially for hepatitis testing. Using the new science of biotechnology, they could make better products for research and therapy. Their idea became Hybritech, San Diego’s first biotech company. By the early 80s, San Diego attracted complementary firms, patent attorneys, venture capitalists and PR companies, all eager to support innovative start-ups, creating medical breakthroughs. Hybritech was sold for $450 million in 1986. Today, a quarter of San Diego’s Life Sciences organizations have roots that can be traced back to Hybritech, reports Biocom. So, I think it’s safe to say there wouldn’t be such a successful biotech business in San Diego without researchers like Royston, who himself went on to become a venture capitalist to invest in local Life Sciences. In the early 90s, as the Cold War was winding down, defense spending in the area had decreased, meaning San Diego-based aerospace companies were closing their doors. The local economy collapsed, and California faced its gravest recession in over 50 years. To secure more biotech business, civic leaders agreed to relax some of the city’s rigid regulations surrounding construction, permits, and zoning. Because of the loosening of rules, along with the research from UCSD, the Salk Institute, the Burnham Institute, and Scripps, a tidal wave of biotech businesses emerged. In 1995, Biocom was formed to be the voice of the Life Sciences industry in California. Today, San Diego’s Life Sciences industry is thriving, from Biotech, Pharmaceutical, Healthcare and Medical Devices. While San Diego has a rich history that has planted its feet firmly in the sand of Life Sciences, start-ups continue to emerge and grow, expanding economic value, attracting skilled workers, and contributing to the INNOVATION Ecosystem. INNOVATE SAN DIEGO will feature the people, products, services, technologies and contributors who make this possible. Please use the link below to submit a thought leader or company who you believe should be showcased as a Life Sciences contributor in the upcoming book, INNOVATE SAN DIEGO. https://lnkd.in/g_ikdGWm #BiotechSD #MedicalDeviceSD #PharmaceuticalSD?